$720 Million is the total value of First Light Asset Management, LLC's 73 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 51.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $43,211,000 | -8.6% | 3,140,347 | +14.5% | 6.00% | -2.3% |
| MODN | Buy | MODEL N INC | $42,481,000 | +11.3% | 2,178,520 | +0.1% | 5.90% | +18.9% |
| ATRC | Buy | ATRICURE INC | $33,174,000 | +35.4% | 1,111,740 | +21.6% | 4.61% | +44.7% |
| MYOK | Buy | MYOKARDIA INC | $26,975,000 | +18.0% | 537,999 | +22.4% | 3.74% | +26.1% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $23,863,000 | -12.1% | 1,800,997 | +0.0% | 3.31% | -6.1% |
| CDXS | Buy | CODEXIS INC | $22,218,000 | +49.5% | 1,205,523 | +66.6% | 3.08% | +59.8% |
| ELGXQ | New | ENDOLOGIX INC | $17,828,000 | – | 2,462,448 | +100.0% | 2.48% | – |
| MYL | Buy | MYLAN N V | $14,162,000 | +53.3% | 743,784 | +128.2% | 1.97% | +63.8% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $14,130,000 | -37.3% | 478,174 | +0.9% | 1.96% | -32.9% |
| SIBN | New | SI-BONE INC | $13,248,000 | – | 651,319 | +100.0% | 1.84% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $12,365,000 | – | 247,897 | +100.0% | 1.72% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INC | $11,431,000 | – | 180,017 | +100.0% | 1.59% | – |
| VAPO | Buy | VAPOTHERM INC | $11,430,000 | +45.8% | 496,969 | +24.6% | 1.59% | +55.7% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $8,974,000 | +82.9% | 972,234 | +210.7% | 1.25% | +95.3% |
| CSII | Buy | CARDIOVASCULAR SYSTEMS INC | $8,115,000 | +11.6% | 189,032 | +0.5% | 1.13% | +19.3% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $7,501,000 | – | 165,397 | +100.0% | 1.04% | – |
| TAK | Buy | TAKEDA PHARMACEUTICAL CO | $7,338,000 | -12.8% | 414,627 | +0.4% | 1.02% | -6.9% |
| SLP | Buy | SIMULATIONS PLUS INC | $7,241,000 | +36.0% | 253,530 | +0.5% | 1.00% | +45.2% |
| TRUP | Buy | TRUPANION INC | $7,037,000 | +10.9% | 194,778 | +0.5% | 0.98% | +18.4% |
| LHCG | Buy | LHC GROUP INC | $6,464,000 | +8.4% | 54,053 | +0.5% | 0.90% | +15.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,002,000 | +2.9% | 70,077 | +6.7% | 0.83% | +9.9% |
| TECH | Buy | BIO TECHNE CORP | $5,940,000 | +11.6% | 28,491 | +6.2% | 0.82% | +19.2% |
| ADRO | Buy | ADURO BIOTECH INC | $5,571,000 | -61.2% | 3,617,653 | +0.2% | 0.77% | -58.6% |
| ALKS | Buy | ALKERMES PLC | $5,140,000 | -33.3% | 228,023 | +8.0% | 0.71% | -28.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $4,929,000 | +0.1% | 26,878 | +0.4% | 0.68% | +6.9% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $4,807,000 | -11.4% | 123,260 | +0.5% | 0.67% | -5.4% |
| NVTRQ | Buy | NUVECTRA CORP | $4,483,000 | -69.6% | 1,338,092 | +0.0% | 0.62% | -67.5% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $3,526,000 | – | 26,920 | +100.0% | 0.49% | – |
| QDEL | Buy | QUIDEL CORP | $3,259,000 | -9.0% | 54,943 | +0.5% | 0.45% | -2.6% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $2,621,000 | – | 44,704 | +100.0% | 0.36% | – |
| EPZM | New | EPIZYME INC | $2,511,000 | – | 200,063 | +100.0% | 0.35% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $2,396,000 | -18.7% | 18,840 | +0.5% | 0.33% | -13.1% |
| HSTM | Buy | HEALTHSTREAM INC | $2,351,000 | -7.5% | 90,924 | +0.4% | 0.33% | -1.2% |
| PSCH | New | INVESCO SMALLCAP HEALTH CARE ETFetf | $2,038,000 | – | 17,285 | +100.0% | 0.28% | – |
| TLGT | Buy | TELIGENT INC | $2,033,000 | +15.8% | 3,227,003 | +113.3% | 0.28% | +23.7% |
| LMAT | Buy | LEMAITRE VASCULAR INC | $1,386,000 | -9.3% | 49,532 | +0.5% | 0.19% | -3.5% |
| CLLS | Buy | CELLECTIS SA | $1,183,000 | -14.5% | 75,843 | +0.6% | 0.16% | -8.9% |
| TMDX | New | TRANSMEDICS GROUP INC | $783,000 | – | 27,000 | +100.0% | 0.11% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC. | $456,000 | – | 3,000 | +100.0% | 0.06% | – |
| AGN | New | ALLERGAN PLC SHS | $361,000 | – | 2,157 | +100.0% | 0.05% | – |
| BAX | New | BAXTER INTERNATIONAL INC | $267,000 | – | 3,258 | +100.0% | 0.04% | – |
| GRFS | New | GRIFOLS SA SPONSORED ADR CLASS B | $215,000 | – | 10,166 | +100.0% | 0.03% | – |
| DHR | New | DANAHER CORP | $200,000 | – | 1,400 | +100.0% | 0.03% | – |
| DYNT | Buy | DYNATRONICS CORP | $194,000 | -18.1% | 117,619 | +2.4% | 0.03% | -12.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.